US Department of Defense gives over $10M to biotech startup Appili Therapeutics to develop biodefense vaccine to prevent a pathogen that’s 1,000 times more infectious than anthrax
Appili Therapeutics, a Nova Scotia, Canada-based biotech startup that focuses on drug development for infectious diseases, announced Tuesday it has received over $10 million in new funding from the US Department of Defense for biodefense vaccine candidate ATI-1701. As part of […]